After buying Apellis for $5.6B, Biogen is cutting most of its pipeline work
Source: news.google.com
Published: Jun 26, 2026 00:50
Source: news.google.com
Published: Jun 26, 2026 00:50
Related Stories
‘Too Good to Be True’: A Chinese Study on Timing Cancer Therapy Is Retracted The New York Times
#Clinical TrialsMedical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning The New York Times
#Clinical TrialsJoseph Gomes, MD, Recognized by Marquis Who's Who for Leadership in Medical Innovation Yahoo Finance
#Health InnovationBIO Notebook: Big Pharmas Help With Entrances; Biotech M&A Offers Exits Citeline News & Insights
#Biotech Headlines‘Too Good to Be True:’ A Chinese Study on Timing Cancer Therapy Is Retracted The New York Times
#Clinical TrialsAt BIO 2026, industry wrestled with Washington politics, and making AI work better statnews.com
#Biotech HeadlinesAdd Shortcut
Open this site faster like an app from your phone home screen.